Longevity Health Holdings, Inc.
XAGE
$0.52
-$0.02-3.39%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.43% | -1.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.43% | -1.33% | |||
| Cost of Revenue | -3.13% | -16.42% | |||
| Gross Profit | -23.62% | 12.19% | |||
| SG&A Expenses | -22.47% | 22.81% | |||
| Depreciation & Amortization | -26.58% | -7.50% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.71% | 17.11% | |||
| Operating Income | 19.60% | -23.35% | |||
| Income Before Tax | 24.20% | -25.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.20% | -25.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.20% | -25.27% | |||
| EBIT | 19.60% | -23.35% | |||
| EBITDA | 19.52% | -23.85% | |||
| EPS Basic | 46.80% | -2.64% | |||
| Normalized Basic EPS | 43.59% | -1.02% | |||
| EPS Diluted | 46.80% | -2.64% | |||
| Normalized Diluted EPS | 43.59% | -1.02% | |||
| Average Basic Shares Outstanding | 42.45% | 22.05% | |||
| Average Diluted Shares Outstanding | 42.45% | 22.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||